Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480943 · ClinicalTrials.gov registry record
Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans
A clinical trial of Thiamine Deficiency and Thiamine Deficiency; Sequelae, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 206
- Enrollment target
- 1
- Study location
NCT05480943: Completed study of Thiamine Deficiency and Thiamine Deficiency; Sequelae, sponsored by VA Office of Research and Development.
NCT05480943 is a study of Thiamine Deficiency and Thiamine Deficiency; Sequelae that has completed, run by VA Office of Research and Development. The registered enrollment target is 206 participants, above the 56-participant average among 3 other Thiamine Deficiency trials with a reported enrollment target (268% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05480943, a study of Thiamine Deficiency and Thiamine Deficiency; Sequelae, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
- 1
- Study location
Study Summary
Thiamine micronutrient deficiency (TD) can cause a variety of non-specific symptoms and leads to several thiamine deficiency disorders such as heart failure, polyneuropathy, Wernicke's Encephalopathy and generalized weakness and debility. Symptoms are often vague and non-specific such as fatigue, leg swelling, imbalance, confusion, mood disorders, gastrointestinal upset, and weakness. Hospitalized Veterans may be particularly susceptible to TD due to food insecurity and chronic illnesses which cause inflammation and increased metabolic demands. This study aims to determine the prevalence of TD in hospitalized Veterans which has never been done before. The investigators also seek to identify risk factors causing TD including acute and chronic forms of inflammation, food insecurity, and dietary habits. Lastly, the investigators hope to clarify the abnormally low levels of blood thiamine that correlate with symptoms of TD that improve with replenishment.
Primary Outcome
The percentage of enrolled non-alcoholic veterans who have thiamine deficiency (defined as low plasma thiamine levels) out of the total number of enrolled Veterans with plasma thiamine results.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Thiamine repletion
Study Locations (1)
Nevada
- VA Sierra Nevada Health Care System, Reno, NV - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2024-12-30 |
What the finished NCT05480943 record still lists
NCT05480943 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 3 other Thiamine Deficiency trials with a reported enrollment target (268% higher).
The record links to 2 conditions, with Thiamine Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Thiamine repletion is the first listed.
NCT05480943 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT05480943 about?
NCT05480943 is a clinical study titled "Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans". Thiamine micronutrient deficiency (TD) can cause a variety of non-specific symptoms and leads to several thiamine deficiency disorders such as heart failure, polyneuropathy, Wernicke's Encephalopathy and generalized weakness and debility. Symptoms are often vague and non-specific such as fatigue, le...
What is the current status of trial NCT05480943?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2022-07-19. Estimated completion is 2024-12-30.
What conditions does trial NCT05480943 study?
This clinical trial studies the following conditions: Thiamine Deficiency, Thiamine Deficiency; Sequelae.
What interventions are being tested in trial NCT05480943?
The interventions under investigation include: Thiamine repletion (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05480943?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480943 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thiamine Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI